Form 4: Hims & Hers Health CFO Oluyemi Okupe Reports Stock Transactions

Oluyemi Okupe, CFO of Hims & Hers Health, reports the vesting and disposal of restricted stock units to cover tax obligations.

Summary

• On March 15, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc. [HIMS], engaged in transactions involving Class A Common Stock.
• Okupe acquired 70,729 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Simultaneously, Okupe disposed of 38,864 shares of Class A Common Stock at a price of $14.63 to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Okupe directly owns 178,539 shares of Class A Common Stock.
• Okupe also holds 419,162 RSUs that vest over a 4-year period, with 25% vesting on March 15, 2023, and the remaining 75% vesting quarterly.
• An additional 220,013 RSUs vest in substantially equal quarterly installments starting June 15, 2023.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a standard disclosure of insider transactions related to stock-based compensation.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Stock-based compensation is a common practice in the tech and healthcare industries, often used to align executive incentives with company performance.
• Similar filings are regularly made by executives at companies like Teladoc, GoodRx, and other telehealth providers.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
• The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates